How to buy dimethyl fumarate (Tecfidera)

Dimethyl fumarate (Tecfidera) is an oral drug used to treat multiple sclerosis (Multiple Sclerosis, MS) and is an immunomodulatory drug. Its active ingredient is dimethyl fumarate, which is thought to slow the progression of the disease by modulating the activity of the immune system.

The original drug of dimethyl fumarate has been launched in China and has been included in medical insurance. Patients can buy it domestically at a price of about 5,000 to 6,000 yuan. Please consult the local hospital pharmacy for specific prices. The main foreign drug is dimethyl fumarate original drug. The cheaper one is the Indian original drug, which costs more than 2,000 yuan and has the same composition and efficacy as the domestic original drug.

Multiple sclerosis is a chronic inflammatory disease of the central nervous system characterized by an immune system attack on the myelin sheath of nerves, resulting in impaired nerve signaling. TecfideraBy suppressing the abnormal activity of the immune system and reducing the inflammatory response, it is expected to slow down the development of the disease and relieve the symptoms associated with it.

The drug's exact mechanism of action is not fully understood, but it is believed to work by modulating the activity of specific immune cells, reducing their aggressive response to the central nervous system. Tecfidera’s oral administration form is relatively convenient, providing patients with a treatment option that is relatively easy to administer.

While usingTecfidera, patients usually need to be monitored by a doctor regularly and may need to undergo a series of examinations to ensure the effectiveness and safety of the drug. Like many medications, Tecfidera may cause side effects, including but not limited to gastrointestinal discomfort, infection, headache, etc.

Before using Tecfidera, patients usually receive a comprehensive medical evaluation, and the doctor will determine whether the drug is suitable for use based on the patient's condition, health status, and other relevant factors. Overall, Tecfidera represents an important advance in the treatment of multiple sclerosis and provides patients with a new treatment option.